An interventional study of RUTF (Plumpynut®) in Weight Loss, Weight Gain and Convalescence, sponsored by Medecins Sans Frontieres, Netherlands. Completed at 1 site in Congo. Open to participants aged 6 Months to 59 Months. Per ClinicalTrials.gov, last updated 2013-10-16.
Sponsored by Medecins Sans Frontieres, Netherlands · Not applicable, Interventional, and Prevention
The primary objective of this study is to determine to what extent provision with RUTF will promote catch up growth in children following an acute uncomplicated episode of P. falciparum malaria.
Anorexia due to infection might lead to weight loss. In many settings total recovery is problematic what might result in a permanent lower weight. A short period high quality food supplementation could improve weight gain after an infection.
Children aged 6-59 months presenting with malaria caused by P. falciparum who are provided with a RUTF supplement (Plumpynut®) of 500 kcal/day for 2 weeks will show significantly better catch up growth compared to a similar patient group not provided with RUTF (at 2 weeks and 4 weeks post-intervention).
317 studies on the registry are indexed under Weight Gain; 48 are open to participants now.
This study's enrollment of 180 is above the median of 83 across 251 interventional studies indexed under Weight Gain.
Browse Weight Gain studies →Medecins Sans Frontieres, Netherlands is the lead sponsor of 15 studies on the registry; 1 is open to participants now.
Compared within Weight Gain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Weight Loss. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
RUTF supplement (Plumpynut®) of 500 kcal/day for 2 weeks
Dietary Supplement: RUTF (Plumpynut®)
no supplement given
Intervention group receives 500 kcal/day of RUTF for 2 weeks Control group receives no food supplement
Also known as: RUTF, Ready to use Therapeutic Food, RUF, Lipid based food supplement
weight gain
Time frame: 14 days
weight gain
Time frame: 28 days
This study is completed, as verified in Oct 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medecins Sans Frontieres, Netherlands